Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANXA2 Expression on Monocytes in Primary APS
NCT06373926Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Cell membrane expression rate of ANXA2 on circulating monocytes at 1 hour. Started Feb 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06373926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06373926.